Impact of Butylphthalide on Homocysteine, CRP and Nerve Function in Patients with Acute Progressive Cerebral Infarction
- VernacularTitle:丁苯酞对急性进展性脑梗死患者血同型半胱氨酸、C反应蛋白及神经功能的影响
- Author:
Yingying YAN
;
Jia MA
- Publication Type:Journal Article
- Keywords:
Butylphthalide;
Acute progressive cerebral infarction;
Homocysteine;
Plasma C reactive protein;
Nerve function
- From:
China Pharmacist
2015;(11):1911-1913
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the impact of butylphthalide on homocysteine, CRP and nerve function in the patients with a-cute progressive cerebral infarction. Methods:Totally 122 cases of patients with acute cerebral infarction were randomly divided into the observation group (n=60) and the control group (n=62). The control group was treated with the routine treatment, and the ob-servation group was treated with butylphthalide additionally. The treatment course was two weeks. The total effective rate, blood Hcy, the level of plasma CRP and the changes of neurological function deficits scale in both groups before and after the treatment were ob-served and compared. Results:The overall response rate in the observation group (81. 67%) was significantly higher than that in the control group (64. 52%). After the treatment, the blood Hcy and CRP in both groups were significantly lower than that before the treatment(P<0. 05), and that of the observation group was significantly lower than that of the control group(P<0. 05). The neuro-logical function deficits scale in both groups were significantly lower than that before the treatment(P<0. 05), and that of the observa-tion group was significantly lower than that of the control group at the same period. The two groups during the treatment showed no sig-nificant adverse reactions. Conclusion: The effect of butylphthalide in the patients with acute cerebral infarction is effective, which can reduce blood Hcy, the level of plasma CRP and the neurological function deficits scale, and improve the neurological function with-out obvious adverse reactions during the treatment course.
